Brief homogeneous TCR signals instruct common iNKT progenitors whose effector diversification is characterized by subsequent cytokine signaling.

IL-17 IL-4 PLZF agonist TCR signals cytokine polarization effector differentiation gene expression dynamics iNKT innate T cell development thymus

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
09 11 2021
Historique:
received: 27 07 2020
revised: 14 09 2020
accepted: 02 09 2021
pubmed: 26 9 2021
medline: 15 12 2021
entrez: 25 9 2021
Statut: ppublish

Résumé

Innate-like T cell populations expressing conserved TCRs play critical roles in immunity through diverse developmentally acquired effector functions. Focusing on the prototypical lineage of invariant natural killer T (iNKT) cells, we sought to dissect the mechanisms and timing of fate decisions and functional effector differentiation. Utilizing induced expression of the semi-invariant NKT cell TCR on double positive thymocytes, an initially highly synchronous wave of iNKT cell development was triggered by brief homogeneous TCR signaling. After reaching a uniform progenitor state characterized by IL-4 production potential and proliferation, effector subsets emerged simultaneously, but then diverged toward different fates. While NKT17 specification was quickly completed, NKT1 cells slowly differentiated and expanded. NKT2 cells resembled maturing progenitors, which gradually diminished in numbers. Thus, iNKT subset diversification occurs in dividing progenitor cells without acute TCR input but utilizes multiple active cytokine signaling pathways. These data imply a two-step model of iNKT effector differentiation.

Identifiants

pubmed: 34562377
pii: S1074-7613(21)00366-6
doi: 10.1016/j.immuni.2021.09.003
pii:
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2497-2513.e9

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Sabrina Bortoluzzi (S)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany.

Nyambayar Dashtsoodol (N)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany; Department of Immunology, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.

Thomas Engleitner (T)

Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich 81675, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Christoph Drees (C)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany.

Sabine Helmrath (S)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany.

Jonas Mir (J)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich 81675, Germany.

Albulena Toska (A)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich 81675, Germany.

Michael Flossdorf (M)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich 81675, Germany.

Rupert Öllinger (R)

Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich 81675, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Maria Solovey (M)

Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg 85764, Germany.

Maria Colomé-Tatché (M)

Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg 85764, Germany; Biomedical Center (BMC), Physiological Chemistry, Faculty of Medicine, LMU Munich, Planegg-Martinsried 82152, Germany.

Bahire Kalfaoglu (B)

Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.

Masahiro Ono (M)

Department of Life Sciences, Imperial College London, London SW7 2AZ, UK.

Thorsten Buch (T)

Institute of Laboratory Animal Science, University of Zurich, Schlieren 8952, Switzerland.

Tim Ammon (T)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany.

Roland Rad (R)

Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich 81675, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Marc Schmidt-Supprian (M)

Institute of Experimental Hematology, School of Medicine, Technical University of Munich, Munich 81675, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich 81675, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg 69120, Germany. Electronic address: marc.supprian@tum.de.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes
Humans Retrospective Studies Male Critical Illness Female

Classifications MeSH